FGFR3 Gene Mutation

Explore clinical trials studying FGFR3 Gene Mutation. Study availability and eligibility vary by location and protocol.

5 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

FGFR3 Gene Mutation trial results

Recruiting

NCT06995677

Conditions: Carcinoma, FGFR Gene Alterations, FGFR Gene Amplification, +18 more
Locations: Urology Centers of Alabama Homewood, Alabama, United States

Arkansas Urology Little Rock, Arkansas, United States

Tri Valley Urology - Murrieta Murrieta, California, United States

Eisenhower Medical Associates Rancho Mirage, California, United States

View all 46 locations

Recruiting

NCT06915753

Conditions: Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +26 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

UCSF Medical Center at Mount Zion San Francisco, California, United States

Stanford Cancer Institute Stanford, California, United States

The University of Kansas Medical Center Westwood, Kansas, United States

View all 16 locations

Completed

NCT02965378

Conditions: FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR2 Gene Amplification, +5 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

View all 1084 locations

Active, Not Recruiting

NCT04917809

Conditions: Bladder Cancer, Carcinoma, FGFR3 Gene Mutation, +15 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States

Active, Not Recruiting

NCT05544552

Conditions: Advanced Solid Tumor, Advanced Urothelial Carcinoma, Bladder Cancer, +31 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

UMass Memorial Medical Center Worchester, Massachusetts, United States

Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States

Duke Cancer Institute (DCI) - Duke Cancer Center Durham, North Carolina, United States

View all 19 locations